The store will not work correctly when cookies are disabled.
2-(3,4-dimethoxyphenyl)-5-(2-(pyridin-3-yl)-5-(trifluoromethoxy)phenyl)-1,3,4-oxadiazole
ID: ALA4551426
PubChem CID: 155555308
Max Phase: Preclinical
Molecular Formula: C22H16F3N3O4
Molecular Weight: 443.38
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(-c2nnc(-c3cc(OC(F)(F)F)ccc3-c3cccnc3)o2)cc1OC
Standard InChI: InChI=1S/C22H16F3N3O4/c1-29-18-8-5-13(10-19(18)30-2)20-27-28-21(31-20)17-11-15(32-22(23,24)25)6-7-16(17)14-4-3-9-26-12-14/h3-12H,1-2H3
Standard InChI Key: UAXDEWNGWUVQAX-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 35 0 0 0 0 0 0 0 0999 V2000
32.8720 -3.9415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8708 -4.7610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5789 -5.1700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2885 -4.7605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2857 -3.9379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5771 -3.5326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5746 -2.7154 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.2811 -2.3047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2787 -1.4875 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
34.9900 -2.7112 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
34.9865 -1.8903 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
34.9969 -5.1680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0841 -5.9782 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.8837 -6.1468 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.2912 -5.4384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7434 -4.8321 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.1079 -5.4356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5169 -6.1437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3328 -6.1412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7395 -5.4320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3243 -4.7238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5097 -4.7298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5567 -5.4280 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.9687 -6.1337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7279 -4.0132 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.5451 -4.0075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5787 -5.9872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8711 -6.3928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8706 -7.2092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5787 -7.6188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2889 -7.2060 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.2859 -6.3909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
7 8 1 0
8 9 1 0
8 10 1 0
8 11 1 0
4 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 12 1 0
15 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
20 23 1 0
23 24 1 0
21 25 1 0
25 26 1 0
3 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 27 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 443.38 | Molecular Weight (Monoisotopic): 443.1093 | AlogP: 5.38 | #Rotatable Bonds: 6 |
Polar Surface Area: 79.50 | Molecular Species: NEUTRAL | HBA: 7 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 7 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 4.64 | CX LogP: 4.55 | CX LogD: 4.55 |
Aromatic Rings: 4 | Heavy Atoms: 32 | QED Weighted: 0.40 | Np Likeness Score: -0.83 |
References
1. Reed CW, Washecheck JP, Quitlag MC, Jenkins MT, Rodriguez AL, Engers DW, Blobaum AL, Conn PJ, Niswender CM, Lindsley CW.. (2019) Surveying heterocycles as amide bioisosteres within a series of mGlu7 NAMs: Discovery of VU6019278., 29 (10): [PMID:30910459] [10.1016/j.bmcl.2019.03.016] |